Rosetta Genomics, Ltd./ IL0011026494 /
2023-11-14 4:48:00 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0000USD | - | 2,166 Turnover: .0022 |
-Bid Size: - | -Ask Size: - | 0.0000 | 0.0000 |
GlobeNewswire
2019-08-06
Predictive Technology Group Names Industry Veteran Dr. E. Robert Wassman Co-Laboratory Director of P...
GlobeNewswire
2019-03-19
Interpace Diagnostics Group Reports Full Year and Fourth Quarter 2018 Financial Results
GlobeNewswire
2018-11-27
RNAi Technologies: Worldwide Market Analysis 2015-2018 and Outlook to 2027 by Therapeutics, Applicat...
GlobeNewswire
2018-10-15
Global Personalized Medicine Market to 2024: Personalized Cancer Therapy Gets a Boost from Patient-D...
GlobeNewswire
2018-08-15
Interpace Diagnostics Acquires Select Assets of Rosetta Genomics Out of Bankruptcy
GlobeNewswire
2018-08-09
Interpace Diagnostics Group Reports Second Quarter 2018 Financial Results, Business Progress and Rec...
GlobeNewswire
2018-07-18
Delisting of Securities of Rosetta Genomics Ltd., ConvergeOne Holdings, Inc. (Warrant Only), FC Glob...
GlobeNewswire
2018-05-23
Global Personalized Medicines Strategic Business Report 2018: Annual Estimates & Forecasts 2016-2024
GlobeNewswire
2018-03-08
2018 $879 Million Clinical Genomics Market By Test Type, Software, Method and End User - Global Fore...
GlobeNewswire
2017-10-12
Global MicroRNA Market to Reach US$ 666.7 Mn by 2025 – Persistence Market Research
GlobeNewswire
2017-10-11
Worldwide Liquid Biopsy Market 2017-2021 by Analyte, Application - Screening/Drug Monitoring/Diagnos...
GlobeNewswire
2017-09-15
Liquid Biopsy Markets by Lung, Breast, Colorectal, Prostate and Others. 2017-2020 Including Screenin...
GlobeNewswire
2017-09-06
Ovid Therapeutics Appoints Ana C. Ward as Senior Vice President and General Counsel